Major Health Contracts and Strikes: A Global Overview

In recent health news, Infosys secures a significant contract from UK's NHS amidst a shifting global economy. Meanwhile, Americans face challenges with new COVID guidelines, and BioCryst strengthens its rare diseases portfolio. Bird flu re-emerges in Iraq, while Kaiser Permanente encounters a labor strike over wage disputes.

In a significant win for Infosys, the Indian software services giant has been awarded a £1.2 billion contract from the UK's National Health Service, marking a pivotal moment for the company amid challenging global economic conditions.

The U.S. is seeing confusion over new COVID-19 vaccine guidelines, which have led to a dramatic 25% drop in immunizations. Meanwhile, BioCryst's acquisition of Astria Therapeutics strengthens its rare disease portfolio with a $700 million deal.

Kaiser Permanente faces a disruptive labor strike affecting its operations, while Iraq reports an outbreak of bird flu. In other developments, the U.S. postpones a planned tariff on Singapore's pharma exports as companies negotiate possible exemptions.

(With inputs from agencies.)